GIM
IMNM icon

Granahan Investment Management’s Immunome IMNM Stock Holding History

Granahan Investment Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.02M Buy
378,542
+71,521
+23% +$1.53M 0.29% 82
2026
Q1 		$6.71M Sell
307,021
-128,102
-29% -$2.85M 0.32% 75
2025
Q4 		$9.35M Buy
435,123
+8,904
+2% +$156K 0.4% 66
2025
Q3 		$4.99M Buy
426,219
+33,468
+9% +$333K 0.2% 98
2025
Q2 		$3.65M Sell
392,751
-26,520
-6% -$217K 0.15% 115
2025
Q1 		$2.82M Buy
419,271
+105,032
+33% +$1.01M 0.14% 122
2024
Q4 		$3.34M Buy
+314,239
New +$3.8M 0.14% 132

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Granahan Investment Management's IMNM Position: Q2 2026 in Review

Granahan Investment Management increased its Immunome (IMNM) stake by 23% in Q2 2026, buying an estimated $1.53M and bringing the position to 378,542 shares worth $8.02M. The position accounts for 0.29% of the portfolio, ranked #82.

Granahan Investment Management first reported a position in IMNM in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.35M in Q4 2025. 203 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Granahan Investment Management held 378,542 shares of Immunome worth $8.02M as of Q2 2026.
  • Granahan Investment Management bought 71,521 Immunome shares in Q2 2026, an estimated $1.53M.
  • Immunome made up 0.29% of Granahan Investment Management's portfolio in Q2 2026, its #82 holding.
  • Granahan Investment Management first reported a position in Immunome in Q4 2024 and has held it in 7 quarters since.
  • Granahan Investment Management's Immunome position peaked at $9.35M in Q4 2025.
  • 203 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Granahan Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.